Physician profile
Regine E Politte
NPI 1063813046
$3,048.23
in general payments reported to CMS, 2019-2025
20 companies · $618 in 2025
The $618 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $616 · 2022: $467 · 2023: $809 · 2024: $538 · 2025: $618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,920 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,920.06 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,232.62 | 2023-2025 | Puraply Wound Matrix, Puraply, Puraply Antimicrobial |
| Smith+Nephew, INC. | $522.56 | 2021-2025 | Pico, Renasys Go V2 Home, Collagenase Santyl |
| Abbvie INC. | $336.70 | 2021-2025 | |
| Lilly USA, LLC | $238.36 | 2021-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $202.83 | 2021-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $132.99 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $55.85 | 2021 | |
| Amgen INC. | $54.29 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $49.81 | 2021 | |
| Phathom Pharmaceuticals, INC. | $28.82 | 2024 | Voquezna |
| Amarin Pharma, INC. | $27.82 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.31 | 2021 | |
| Radius Health, INC. | $23.70 | 2021 | |
| Medline Industries LP | $23.50 | 2024 | |
| Abbott Laboratories | $18.48 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $17.40 | 2025 | Ibsrela |
| Corcept Therapeutics | $16.90 | 2021 | |
| Ets Wound Care LLC | $14.69 | 2025 | Mirragen Advanced Wound Matrix |
| Paratek Pharmaceuticals, INC. | $13.25 | 2022 | |
| Kerecis Limited | $12.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regine Politte listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.